MAR002

DRUG2 trials

Sponsors

Marea Therapeutics

Conditions

Acromegaly

Phase 1

Study of MAR002 in Healthy Men

RecruitingNCT07195175

Marea TherapeuticsAcromegaly

Start: 2025-08-11End: 2026-07-31Target: 45Updated: 2026-01-12

Phase 2

A Study to Evaluate MAR002 for Acromegaly

RecruitingNCT07641179

Marea TherapeuticsAcromegaly

Start: 2026-07-23End: 2027-12-01Target: 72Updated: 2026-09-11